Sub-Inhibitory Concentrations of Mupirocin Strongly Inhibit Alpha-Toxin Production in High-Level Mupirocin-Resistant MRSA by Down-Regulating agr, saeRS, and sarA
Open Access
- 15 May 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 9, 993
Abstract
Mupirocin, a topical antibiotic, has been utilized for decades to treat Staphylococcus aureus skin infections, as well as to decolonize patients at risk of methicillin-resistant S. aureus (MRSA) infection. The aims of this study were to investigate the expression of α-toxin (encoded by the hla gene) in ten clinical MRSA strains (MIC = 1024 μg/ml) in response to a sub-inhibitory concentration of mupirocin (1/32 minimum inhibitory concentration [MIC]) (32 μg/ml) by using α-toxin activity determination and enzyme-linked immune sorbent assay (ELISA). Subsequently, real-time polymerase chain reaction (RT-PCR) was used to examine the expression of saeR, agrA, RNAIII, and sarA genes under sub-inhibitory concentration of mupirocin in order to investigate the mechanism of action of this treatment regarding its strong inhibition of α-toxin expression. For all the strains tested, mupirocin dramatically reduced mRNA levels of α-toxin. The results indicated that α-toxin activity in mupirocin-treated groups was significantly lower than that in untreated groups. The results show that the levels of agrA, RNAIII, saeR, and sarA expression significantly decrease by 11.82- to 2.23-fold (P < 0.01). Moreover, we speculate that mupirocin-induced inhibition of α-toxin expression may be related to the inhibition of regulatory loci, such as agr, sarA and saeRS. More specifically, we found that the mechanism involves inhibiting the expression of agrA and RNAIII. In conclusion, sub-inhibitory concentrations of mupirocin strongly inhibit alpha-toxin production in high-level mupirocin-resistant MRSA by down-regulating agr, saeRS and sarA, which could potentially be developed as a supplemental treatment to control high-level mupirocin-resistant MRSA infection and reduce the risk of infection and colonization.Keywords
Funding Information
- National Natural Science Foundation of China (81672078)
This publication has 25 references indexed in Scilit:
- Staphylococcal decolonisation: an effective strategy for prevention of infection?The Lancet Infectious Diseases, 2011
- Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging EpidemicClinical Microbiology Reviews, 2010
- Resistance to and synthesis of the antibiotic mupirocinNature Reviews Microbiology, 2010
- Effects of Subinhibitory Concentrations of Antibiotics on Colonization Factor Expression by Moxifloxacin-Susceptible and Moxifloxacin-Resistant Clostridium difficile StrainsAntimicrobial Agents and Chemotherapy, 2009
- Regulation ofStaphylococcus aureusα‐Toxin Gene(hla)Expression byagr, sarA,andsaeIn Vitro and in Experimental Infective EndocarditisThe Journal of Infectious Diseases, 2006
- The world of subinhibitory antibiotic concentrationsCurrent Opinion in Microbiology, 2006
- Novel Multiplex PCR Assay for Characterization and Concomitant Subtyping of Staphylococcal Cassette ChromosomemecTypes I to V in Methicillin-ResistantStaphylococcus aureusJournal of Clinical Microbiology, 2005
- Subinhibitory Clindamycin Differentially Inhibits Transcription of Exoprotein Genes in Staphylococcus aureusInfection and Immunity, 2001
- Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA)Journal of Hospital Infection, 1997
- Transcriptional control of the agr‐dependent virulence gene regulator, RNAIII, in Staphylococcus aureusMolecular Microbiology, 1996